Price target upside
Harmony Biosciences Holdings Price Target: +19.4% vs Current Price
HRMY target gap is +19.4% from $39.66 to $47.36. As of 2026-08-27.
Direct answer
Harmony Biosciences Holdings's analyst target implies +19.4%.
The average target is $47.36 compared with a recorded current price of $39.66.
This percentage is calculated from the verified average target and recorded market price.
Forecast evidence checked August 27, 2026.
Get free Harmony Biosciences Holdings email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $39.66
- Average price target
- $47.36
- High price target
- $70.00
- Low price target
- $30.00
- Low target gap
- -24.4%
- Target upside
- +19.4%
- High target gap
- +76.5%
- Target range width
- 100.9%
- Consensus rating
- Buy
- Analysts
- 11
- Evidence date
- August 27, 2026
- Valid through
- September 3, 2026
Explore related company data
Read the frequently asked questions.
How much upside or downside does Harmony Biosciences Holdings's average target imply?
Harmony Biosciences Holdings's average target is $47.36 versus a recorded price of $39.66. The difference is +19.4%.
How far are Harmony Biosciences Holdings's low and high targets from the recorded price?
The low target implies -24.4%, while the high target implies +76.5%.
How many analysts are included in Harmony Biosciences Holdings's consensus?
The verified consensus includes 11 analysts.
How is Harmony Biosciences Holdings's target upside or downside calculated?
The average target of $47.36 is divided by the recorded price of $39.66, then one is subtracted to produce +19.4%. This does not guarantee a future return.
When was Harmony Biosciences Holdings's analyst forecast verified?
The data was verified on 2026-08-27. The dataset is valid through 2026-09-03.